LTFS
IMNP

Ladenburg Thalmann Financial Services’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50
Closed – – 5121
2017
Q2 		$0 Hold
50
– – ﹤0.01% 5062
2017
Q1 		$0 Sell
50
-1,325
-96% -$4.78K ﹤0.01% 5067
2016
Q4 		$5K Buy
1,375
+1,275
+1,275% +$5.24K ﹤0.01% 4272
2016
Q3 		$0 Buy
100
+50
+100% +$369 ﹤0.01% 4952
2016
Q2 		$0 Hold
50
– – ﹤0.01% 4924
2016
Q1 		$0 Hold
50
– – ﹤0.01% 4906
2015
Q4 		$1K Hold
50
– – ﹤0.01% 4603
2015
Q3 		$1K Hold
50
– – ﹤0.01% 4521
2015
Q2 		$2K Hold
50
– – ﹤0.01% 4401
2015
Q1 		$2K Buy
+50
New +$1.87K ﹤0.01% 4344

Other funds holding IMNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IMNP Position: Q3 2017 in Review

Ladenburg Thalmann Financial Services sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2017, closing a stake of 50 shares.

Ladenburg Thalmann Financial Services first reported a position in IMNP in Q1 2015 and held it in 10 quarters. The position peaked at $5K in Q4 2016. 12 funds tracked by Wall St. Rank hold IMNP as of Q3 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 50 Immune Pharmaceuticals Inc. shares in Q3 2017.
  • Ladenburg Thalmann Financial Services first reported a position in Immune Pharmaceuticals Inc. in Q1 2015 and held it in 10 quarters.
  • Ladenburg Thalmann Financial Services's Immune Pharmaceuticals Inc. position peaked at $5K in Q4 2016.
  • 12 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2017, filed 15 Nov 2017.